Interactive Discussions

Monday, May 18

4:00 pm Interactive Breakout Discussions (IN-PERSON ONLY)

Interactive Breakout Discussions are informal, moderated discussions, allowing participants to exchange ideas and experiences and develop future collaborations around a focused topic. Each breakout will be led by a facilitator who keeps the discussion on track and the group engaged. Please visit the Interactive Breakout Discussions page on the conference website for a complete listing of topics and descriptions. Interactive Breakout Discussions are offered in-person only.

TABLE 1: Translating Healthcare AI Success into Clinical

Pratik Shah, PhD, Professor, Pathology & Laboratory Medicine, Electrical Engineering & Computer Science, and Biomedical Engineering, University of California

TABLE 2: AI-Ready Clinical Data

Kristian Hammond, PhD, Professor, Computer Science, Northwestern University; Director, The Center for Advancing Safety of Machine Intelligence (CASMI)

TABLE 3: KPIs of AI Adoption and ROI

Subha Madhavan, PhD, Vice President and Head, AI/ML, Quantitative and Digital Sciences, Pfizer Inc.

TABLE 4: Regulatory Landscape for AI in Clinical Development

Kevin Bugin, PhD, Head, Regulatory Policy and Intelligence, Amgen

M. Khair ElZarrad, PhD, MPH, Vice President, Regulatory Policy, BridgeBio; Former Deputy Director Office of Medical Policy, Center for Drug Evaluation & Research, FDA CDER

TABLE 5: Applying AI at the Site Level

Jimmy Bechtel, Chief Site Success Officer, Society for Clinical Research Sites (SCRS)

TABLE 6: AI-Powered Patient Recruitment and Retention

Anastasia Christianson, PhD, Pharma Industry Data Science Leader

Michelle Everill, Vice President, Global Trial Optimization, Alnylam Pharmaceuticals

TABLE 7: Leveraging AI in RBQM

Brian Barnes, Director, Risk Management Strategy, Global Clinical Development Operations, BioNTech US

4:40 pm Networking Reception in the Exhibit Hall